Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellgram-LC in Patients With Alcoholic Liver Cirrhosis
NCT04689152Phase 3Recruiting
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Apr 2021
- Primary completion
- Dec 2029
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Cellgram-LC in alcoholic cirrhosis, sponsored by Pharmicell Co., Ltd.. Started Apr 2021; status: recruiting.
02
Drugs
Cellgram-LC
03
Conditions
alcoholic cirrhosis
Beyond the preview
Go deeper on NCT04689152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04689152.